These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Current practice compared with the international guidelines: endoscopic surveillance of Barrett's esophagus. Amamra N; Touzet S; Colin C; Ponchon T J Eval Clin Pract; 2007 Oct; 13(5):789-94. PubMed ID: 17824873 [TBL] [Abstract][Full Text] [Related]
43. Bladder cancer: epidemiology, staging and grading, and diagnosis. Kirkali Z; Chan T; Manoharan M; Algaba F; Busch C; Cheng L; Kiemeney L; Kriegmair M; Montironi R; Murphy WM; Sesterhenn IA; Tachibana M; Weider J Urology; 2005 Dec; 66(6 Suppl 1):4-34. PubMed ID: 16399414 [TBL] [Abstract][Full Text] [Related]
44. Evaluation of urine CYFRA 21-1 for the detection of primary and recurrent bladder carcinoma. Nisman B; Barak V; Shapiro A; Golijanin D; Peretz T; Pode D Cancer; 2002 Jun; 94(11):2914-22. PubMed ID: 12115379 [TBL] [Abstract][Full Text] [Related]
45. [Tumors of the urinary bladder. Report from a Committee of the Danish Urological society from 1978]. Ugeskr Laeger; 1982 Apr; 144(15):1063-74. PubMed ID: 7101558 [No Abstract] [Full Text] [Related]
46. European Association of Urology and American Urological Association/Society of Urologic Oncology Guidelines on Risk Categories for Non-muscle-invasive Bladder Cancer May Lead to Overtreatment for Low-grade Ta Bladder Tumors. Klaassen Z; Soloway MS Urology; 2017 Jul; 105():14-17. PubMed ID: 28366700 [No Abstract] [Full Text] [Related]
47. [Treatment of bladder tumors by "Amsterdam Team on Urological Tumors"]. Scholtmeijer RJ; Donner R; Thierie AH Ned Tijdschr Geneeskd; 1976 Jan; 120(3):83-7. PubMed ID: 1246362 [No Abstract] [Full Text] [Related]
54. [Treatment of bladder tumors at a county hospital--a proposal for a care program]. Berge T; Hedenberg I Lakartidningen; 1980 Oct; 77(43):3877-80. PubMed ID: 7453368 [No Abstract] [Full Text] [Related]
55. Essential content of evidence-based clinical practice guidelines for bladder cancer: The Japanese Urological Association 2015 update. Kubota Y; Nakaigawa N; Int J Urol; 2016 Aug; 23(8):640-5. PubMed ID: 27374472 [TBL] [Abstract][Full Text] [Related]
56. Phase II trials in Ta, T1 bladder cancer. The marker tumour concept. van der Meijden AP; Hall RR; Kurth KH; Bouffioux C; Sylvester R Br J Urol; 1996 May; 77(5):634-7. PubMed ID: 8689102 [No Abstract] [Full Text] [Related]